224 related articles for article (PubMed ID: 8970454)
1. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial.
Valiquette G; Herbert J; Maede-D'Alisera P
Arch Neurol; 1996 Dec; 53(12):1270-5. PubMed ID: 8970454
[TBL] [Abstract][Full Text] [Related]
2. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis.
Eckford SD; Swami KS; Jackson SR; Abrams PH
Br J Urol; 1994 Dec; 74(6):733-5. PubMed ID: 7827843
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin for nocturia and enuresis associated with multiple sclerosis.
Ferreira E; Letwin SR
Ann Pharmacother; 1998 Jan; 32(1):114-6. PubMed ID: 9475830
[No Abstract] [Full Text] [Related]
5. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns.
Rembratt A; Norgaard JP; Andersson KE
BJU Int; 2003 May; 91(7):642-6. PubMed ID: 12699476
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin: in adults with nocturia.
Cvetković RS; Plosker GL
Drugs; 2005; 65(1):99-107; discussion 108-9. PubMed ID: 15610055
[TBL] [Abstract][Full Text] [Related]
7. An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia.
Eckford SD; Carter PG; Jackson SR; Penney MD; Abrams P
Br J Urol; 1995 Oct; 76(4):459-63. PubMed ID: 7551881
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women.
Lose G; Lalos O; Freeman RM; van Kerrebroeck P;
Am J Obstet Gynecol; 2003 Oct; 189(4):1106-13. PubMed ID: 14586363
[TBL] [Abstract][Full Text] [Related]
9. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
Hilton P; Hertogs K; Stanton SL
J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):854-5. PubMed ID: 6619893
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.
Mattiasson A; Abrams P; Van Kerrebroeck P; Walter S; Weiss J
BJU Int; 2002 Jun; 89(9):855-62. PubMed ID: 12010228
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
Bosma R; Wynia K; Havlíková E; De Keyser J; Middel B
Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
[TBL] [Abstract][Full Text] [Related]
12. Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis.
Hoverd PA; Fowler CJ
J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):778-80. PubMed ID: 9810957
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2019 Feb; 38(2):563-571. PubMed ID: 30653737
[TBL] [Abstract][Full Text] [Related]
14. Long term use of desmopressin for urinary symptoms in multiple sclerosis.
Tubridy N; Addison R; Schon F
Mult Scler; 1999 Dec; 5(6):416-7. PubMed ID: 10618698
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years.
Kuo HC
Urology; 2002 Apr; 59(4):485-9. PubMed ID: 11927295
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.
Nevéus T; Läckgren G; Tuvemo T; Olsson U; Stenberg A
J Urol; 1999 Dec; 162(6):2136-40. PubMed ID: 10569604
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
[TBL] [Abstract][Full Text] [Related]
18. Nocturia: a new perspective on an old symptom.
Lundgren R
Scand J Urol Nephrol; 2004; 38(2):112-6. PubMed ID: 15204390
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ
J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
[TBL] [Abstract][Full Text] [Related]
20. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.
Asplund R; Sundberg B; Bengtsson P
BJU Int; 1999 Apr; 83(6):591-5. PubMed ID: 10233563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
